Revolutionizing Rheumatoid Arthritis Therapy: Harnessing Cytomembrane Biomimetic Nanoparticles for Novel Treatment Strategies

Lan Ma,Xinchi Jiang,Jianqing Gao

DOI: https://doi.org/10.1007/s13346-024-01605-x

2024-01-01

Drug Delivery and Translational Research

Abstract:Rheumatoid arthritis (RA) is a systemic immune disease with severe implications for joint health. The issue of non-specific drug distribution potentially limits the therapeutic efficacy and increases the risk associated with RA treatment. Researchers employed cytomembrane-coated biomimetic nanoparticles (NPs) to enhance the targeting delivery efficacy to meet the demand for drug accumulation within the affected joints. Furthermore, distinct cytomembranes offer unique functionalities, such as immune cell activation and augmented NP biocompatibility. In this review, the current strategies of RA treatments were summarized in detail, and then an overview of RA’s pathogenesis and the methodologies for producing cytomembrane-coated biomimetic NPs was provided. The application of cytomembrane biomimetic NPs derived from various cell sources in RA therapy is explored, highlighting the distinctive attributes of individual cytomembranes as well as hybrid membrane configurations. Through this comprehensive assessment of cytomembrane biomimetic NPs, we elucidate the prospective applications and challenges in the realm of RA therapy, and the strategy of combined therapy is proposed. In the future, cytomembrane biomimetic NPs have a broad therapeutic prospect for RA. Illustration depicting diverse strategies for generating cytomembrane biomimetic nanoparticles (NPs). Cellular membranes are harvested through distinct methodologies, and subsequently fused with polymer NPs to facilitate the encapsulation of various therapeutic agents, thereby generating cell membrane biomimetic preparations. This innovative approach holds potential for rheumatoid arthritis (RA) treatment, underscored by its intrinsic targeting precision, anti-inflammatory attributes, and favorable biocompatibility. (Figure created using )